These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30102653)

  • 21. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
    Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
    J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy.
    Sun H; Kim D; Li X; Kiselinova M; Ouyang Z; Vandekerckhove L; Shang H; Rosenberg ES; Yu XG; Lichterfeld M
    J Virol; 2015 Nov; 89(22):11284-93. PubMed ID: 26339043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy.
    Mallarino-Haeger C; Pino M; Viox EG; Pagliuzza A; King CT; Nguyen K; Harper JL; Aldrete SDM; Cervasi B; Delman KA; Lowe MC; Chomont N; Marconi VC; Paiardini M
    J Virol; 2023 Apr; 97(4):e0167022. PubMed ID: 36971588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Deep lung--cellular reaction to HIV].
    Tavares Marques MA; Alves V; Duque V; Botelho MF
    Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART.
    Bacchus-Souffan C; Fitch M; Symons J; Abdel-Mohsen M; Reeves DB; Hoh R; Stone M; Hiatt J; Kim P; Chopra A; Ahn H; York VA; Cameron DL; Hecht FM; Martin JN; Yukl SA; Mallal S; Cameron PU; Deeks SG; Schiffer JT; Lewin SR; Hellerstein MK; McCune JM; Hunt PW
    PLoS Pathog; 2021 Jan; 17(1):e1009214. PubMed ID: 33465157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.
    Bachtel ND; Beckerle GA; Mota TM; Rougvie MM; Raposo RAS; Jones RB; Nixon DF; Apps R
    AIDS Res Hum Retroviruses; 2019 Jan; 35(1):108-111. PubMed ID: 30198299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART.
    Delobel P; Sandres-Sauné K; Cazabat M; L'Faqihi FE; Aquilina C; Obadia M; Pasquier C; Marchou B; Massip P; Izopet J
    AIDS; 2005 Nov; 19(16):1739-50. PubMed ID: 16227781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.
    Mehandru S; Poles MA; Tenner-Racz K; Jean-Pierre P; Manuelli V; Lopez P; Shet A; Low A; Mohri H; Boden D; Racz P; Markowitz M
    PLoS Med; 2006 Dec; 3(12):e484. PubMed ID: 17147468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.
    Tanaskovic S; Fernandez S; Price P; French MA
    AIDS; 2014 Mar; 28(6):821-30. PubMed ID: 24499954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
    Gandhi RT; McMahon DK; Bosch RJ; Lalama CM; Cyktor JC; Macatangay BJ; Rinaldo CR; Riddler SA; Hogg E; Godfrey C; Collier AC; Eron JJ; Mellors JW;
    PLoS Pathog; 2017 Apr; 13(4):e1006285. PubMed ID: 28426825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.
    Ananworanich J; Puthanakit T; Suntarattiwong P; Chokephaibulkit K; Kerr SJ; Fromentin R; Bakeman W; Intasan J; Mahanontharit A; Sirivichayakul S; Chomont N;
    AIDS; 2014 Apr; 28(7):1015-20. PubMed ID: 24384692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    Fromentin R; Bakeman W; Lawani MB; Khoury G; Hartogensis W; DaFonseca S; Killian M; Epling L; Hoh R; Sinclair E; Hecht FM; Bacchetti P; Deeks SG; Lewin SR; Sékaly RP; Chomont N
    PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease.
    Popescu I; Drummond MB; Gama L; Lambert A; Hoji A; Coon T; Merlo CA; Wise RA; Keruly J; Clements JE; Kirk GD; McDyer JF
    J Infect Dis; 2016 Nov; 214(10):1520-1530. PubMed ID: 27613775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in terminally differentiated T cells in virologically controlled HIV-infected aging patients on long-term antiretroviral therapy.
    Behrens NE; Wertheimer A; Klotz SA; Ahmad N
    PLoS One; 2018; 13(6):e0199101. PubMed ID: 29897981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations.
    Hani L; Chaillon A; Nere ML; Ruffin N; Alameddine J; Salmona M; Lopez Zaragoza JL; Smith DM; Schwartz O; Lelièvre JD; Delaugerre C; Lévy Y; Seddiki N
    PLoS Pathog; 2019 Jun; 15(6):e1007868. PubMed ID: 31220191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.
    Jambo KC; Banda DH; Afran L; Kankwatira AM; Malamba RD; Allain TJ; Gordon SB; Heyderman RS; Russell DG; Mwandumba HC
    Am J Respir Crit Care Med; 2014 Oct; 190(8):938-47. PubMed ID: 25225948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired Upregulation of the Costimulatory Molecules, CD27 and CD28, on CD4
    Tanaskovic S; Price P; French MA; Fernandez S
    AIDS Res Hum Retroviruses; 2017 Feb; 33(2):101-109. PubMed ID: 27701900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.